Michael Alfieri, Principal Financial Officer at Aldeyra Therapeutics, Inc. (ALDX), bought 2,500 shares at $5.30 ($13K) on 2025-08-13, disclosed to the SEC on 2025-08-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |